OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(08)61411-7
Authors: Anne Katrin Sjølie, Ronald Klein, Massimo Porta, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Nish Chaturvedi
Institutions: Odense University Hospital, University of Wisconsin–Madison, University of Turin, University of Pittsburgh, University College London, Copenhagen University Hospital, Imperial College Healthcare NHS Trust
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: candesartan, diabetic retinopathy, type 2 diabetes, retinopathy progression, retinopathy regression, angiotensin receptor blockers, blindness prevention, blood pressure, adverse events, normoalbuminuria, hypertension, normotension, dose escalation, treatment discontinuation, retinopathy screening
SDG: Good health and well-being

Open Access status: green

Funder: AstraZeneca
OpenAlex ID: W2109689720
FWCI: 41.81
Cites: 51
Cited by: 465
Related to: 7
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security